The Indira IVF medical assistant says the IPO Citit withdrawal

The Indira IVF Hospital Chain Wednesday said it was filed an IPO, which follows the assessment of factors and trade considerations.

The decision has happened to the company’s temporary withdrawal for the launch of the market, match Bollywood Biopin releases in the founder of the Founder, Ajay Murdia.

The report indicates that SEBI has received a notice of the situation and the potential advertising when the IPO is not disclosed to the people.

Biopic, starring Anto Anupam Kher and ESha Deol, was released on March 21. Release came only more than one month after applying IPO.

The initial IPO documents are obtained by Indian stock and exchanges (Sebi) on February 19th, 2025 “, according to public updates by Tuesday.

A secret abuse of transgressions allow companies that can reveal human details under the body of the body (DRHP).

Furthermore, DRHP Ahead does not guarantee the company will continue to be awarded to the initial public offering (IPO).

In a statement, spokesman of Indira IVF hospital, “The company decided to withdraw DRHP pre-filed by evaluation of factors and trade considerations.” “Reports recommended to any direction from Sebi in this regard,” statement said.

Last week, the Physics participated in companies with companies that have filled a secret path for its IPO.

In 2024, Delivery Swiggy Swiggy Swiggy and Supermart Sinimart Vshal Mega Mart has reduced the secret initial sales after expression.

Before here, the hotel carrier Oyo hotel brings a secret path in 2023 but not to run with the initial stocks. Tata play, previously known when Tata Sky, is the first company in India to have the observative letter of the supervisor in December. However, the company is not proceeded.

Under the road before filing the file, no pressure against the company to go for IPO, experts.

Furthermore, not like the traditional line that the company must launch an IPO within 12 months from the SEBI path from the date of the last comment of Sebi. This route also provides flexibility to change the main issue by 50 percent to the process of promoting the body prospects (UDRHP).